Skip to main
MDT

Medtronic (MDT) Stock Forecast & Price Target

Medtronic (MDT) Analyst Ratings

Based on 20 analyst ratings
Buy
Strong Buy 30%
Buy 40%
Hold 30%
Sell 0%
Strong Sell 0%

Bulls say

Medtronic is a strong and stable medical-device company with a positive outlook due to its diverse portfolio, international market presence, and promising pipeline. The company's projected revenue growth and potential investment opportunities make it an attractive choice for investors. However, there are some potential risks to consider, such as inconsistent execution and competition in the market. Overall, Medtronic's strong financial performance and potential for further growth make it a favorable stock for investment in the long term.

Bears say

Medtronic is facing potential headwinds in the upcoming years, including market share loss in key product categories and unsuccessful new product launches, which could lead to revenue growth slowing to less than 5%. Additionally, macroeconomic volatility could impact the company's operations and revenue growth, and there is risk of slower earnings growth and ROIC expansion if management fails to prudently allocate capital at accretive returns. With a negative outlook, our forecasted price target is lower than the current share price.

Medtronic (MDT) has been analyzed by 20 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 40% recommend Buy, 30% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medtronic (MDT) Forecast

Analysts have given Medtronic (MDT) a Buy based on their latest research and market trends.

According to 20 analysts, Medtronic (MDT) has a Buy consensus rating as of Aug 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $101.95, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $101.95, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medtronic (MDT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.